Investor Presentaiton slide image

Investor Presentaiton

18 Venus-Vitae On December 16, 2021 the Company successfully completed the first two implantations in the First-in-Man clinical trial at Instituto De Cardiologia Hospital in Argentina. Feature 日 启明医疗® VENUSMEDTECH vitae Balloon-expandable TAVR ➤Valve lock wire design ensures accurate positioning and deployment ➤ Supra-annular prosthesis design Dry tissue for durability, storage and calcification reduction
View entire presentation